Folate Receptor Alpha, Mesothelin and Megakaryocyte Potentiating Factor as Potential Serum Markers of Chronic Kidney Disease

Por Somers, Elizabeth B, O’Shannessy, Daniel J
Publicado em 2014

Co-Development of Diagnostic Vectors to Support Targeted Therapies and Theranostics: Essential Tools in Personalized Cancer Therapy

Por Nicolaides, Nicholas C., O’Shannessy, Daniel J., Albone, Earl, Grasso, Luigi
Publicado em 2014

Isolation of Circulating Tumor Cells from Multiple Epithelial Cancers with ApoStream(®) for Detecting (or Monitoring) the Expression of Folate Receptor Alpha

Por O’Shannessy, Daniel J., Davis, Darren W., Anderes, Kenna, Somers, Elizabeth B.
Publicado no Biomark Insights (2016)

Folate receptor alpha (FRA) expression in breast cancer: identification of a new molecular subtype and association with triple negative disease

Por O’Shannessy, Daniel J, Somers, Elizabeth B, Maltzman, Julia, Smale, Robert, Fu, Yao-Shi
Publicado em 2012

Expression of folate receptors alpha and beta in normal and cancerous gynecologic tissues: correlation of expression of the beta isoform with macrophage markers

Por O’Shannessy, Daniel J, Somers, Elizabeth B, Wang, Li-chong, Wang, Hongwei, Hsu, Ruby
Publicado no J Ovarian Res (2015)

Endosialin and Associated Protein Expression in Soft Tissue Sarcomas: A Potential Target for Anti-Endosialin Therapeutic Strategies

Por O'Shannessy, Daniel J., Dai, Hongyue, Mitchell, Melissa, Huntsman, Shane, Brantley, Stephen, Fenstermacher, David, Reed, Damon R.
Publicado no Sarcoma (2016)

Influence of tumor microenvironment on prognosis in colorectal cancer: Tissue architecture-dependent signature of endosialin (TEM-1) and associated proteins

Por O'Shannessy, Daniel J., Somers, Elizabeth B., Chandrasekaran, Lakshmi K., Nicolaides, Nicholas C., Bordeaux, Jennifer, Gustavson, Mark D.
Publicado em 2014

Development of (89)Zr-Ontuxizumab for in vivo TEM-1/endosialin PET applications

Por Lange, Sara E.S., Zheleznyak, Alex, Studer, Matthew, O'Shannessy, Daniel J., Lapi, Suzanne E., Van Tine, Brian A.
Publicado no Oncotarget (2016)

Serum folate receptor alpha, mesothelin and megakaryocyte potentiating factor in ovarian cancer: association to disease stage and grade and comparison to CA125 and HE4

Por O’Shannessy, Daniel J, Somers, Elizabeth B, Palmer, Leslie M, Thiel, Robert P, Oberoi, Pankaj, Heath, Ryan, Marcucci, Lisa
Publicado em 2013

Folate Receptor Alpha Expression in Lung Cancer: Diagnostic and Prognostic Significance

Por O'Shannessy, Daniel J., Yu, Gordon, Smale, Robert, Fu, Yao-Shi, Singhal, Sunil, Thiel, Robert P., Somers, Elizabeth B., Vachani, Anil
Publicado em 2012

Gene Expression Analyses Support Fallopian Tube Epithelium as the Cell of Origin of Epithelial Ovarian Cancer

Por O’Shannessy, Daniel J., Jackson, Stephen M., Twine, Natalie C., Hoffman, Bryan E., Dezso, Zoltan, Agoulnik, Sergei I., Somers, Elizabeth B.
Publicado em 2013

Endosialin Expression in Metastatic Melanoma Tumor Microenvironment Vasculature: Potential Therapeutic Implications

Por Kiyohara, Eiji, Donovan, Nicholas, Takeshima, Ling, Huang, Sharon, Wilmott, James S., Scolyer, Richard A., Jones, Peter, Somers, Elizabeth B., O’Shannessy, Daniel J., Hoon, Dave S. B.
Publicado no Cancer Microenviron (2015)

Phase II clinical trial of amatuximab, a chimeric anti-mesothelin antibody with pemetrexed and cisplatin in advanced unresectable pleural mesothelioma

Por Hassan, Raffit, Kindler, Hedy L., Jahan, Thierry, Bazhenova, Lyudmila, Reck, Martin, Thomas, Anish, Pastan, Ira, Parno, Jeff, O’Shannessy, Daniel J., Fatato, Penny, Maltzman, Julia D., Wallin, Bruce A.
Publicado no Clin Cancer Res (2014)

A First-in-Human Phase I Study of MORAb-004, a Monoclonal Antibody to Endosialin in Patients with Advanced Solid Tumors

Por Diaz, Luis A., Coughlin, Christina M., C.Weil, Susan, Fishel, Jean, Gounder, Mrinal M., Lawrence, Susan, Azad, Nilofer, O'Shannessy, Daniel J., Grasso, Luigi, Wustner, Jason, Ebel, Wolfgang, Carvajal, Richard D.
Publicado no Clin Cancer Res (2014)

Characterization of the Human Folate Receptor Alpha Via Novel Antibody-Based Probes

Por O'Shannessy, Daniel J., Somers, Elizabeth B., Albone, Earl, Cheng, Xin, Park, Young Chul, Tomkowicz, Brian E., Hamuro, Yoshitomo, Kohl, Thomas O., Forsyth, Tracy M., Smale, Robert, Fu, Yao-Shi, Nicolaides, Nicholas C.
Publicado em 2011

Novel antibody probes for the characterization of endosialin/TEM-1

Por O'shannessy, Daniel J., Smith, Michael F., Somers, Elizabeth B., Jackson, Stephen M., Albone, Earl, Tomkowicz, Brian, Cheng, Xin, Park, Young, Fernando, Danielle, Milinichik, Andrew, Kline, Brad, Fulton, Regan, Oberoi, Pankaj, Nicolaides, Nicholas C.
Publicado no Oncotarget (2016)

Significance of Folate Receptor alpha and Thymidylate Synthase Protein Expression in Patients with Non-Small Cell Lung Cancer treated with Pemetrexed

Por Christoph, Daniel C, Asuncion, Bernadette Reyna, Hassan, Biftu, Tran, Cindy, Maltzman, Julia D, O’Shannessy, Daniel J, Wynes, Murry W, Gauler, Thomas C, Wohlschlaeger, Jeremias, Hoiczyk, Mathias, Schuler, Martin, Eberhardt, Wilfried E, Hirsch, Fred R
Publicado em 2013

Folate Receptor-α (FOLR1) Expression and Function in Triple Negative Tumors

Por Necela, Brian M., Crozier, Jennifer A., Andorfer, Cathy A., Lewis-Tuffin, Laura, Kachergus, Jennifer M., Geiger, Xochiquetzal J., Kalari, Krishna R., Serie, Daniel J., Sun, Zhifu, Aspita, Alvaro Moreno, O’Shannessy, Daniel J., Maltzman, Julia D., McCullough, Ann E., Pockaj, Barbara A., Cunliffe, Heather E., Ballman, Karla V., Thompson, E. Aubrey, Perez, Edith A.
Publicado no PLoS One (2015)

Correction: Folate Receptor-α (FOLR1) Expression and Function in Triple Negative Tumors

Por Necela, Brian M., Crozier, Jennifer A., Andorfer, Cathy A., Lewis-Tuffin, Laura, Kachergus, Jennifer M., Geiger, Xochiquetzal J., Kalari, Krishna R., Serie, Daniel J., Sun, Zhifu, Moreno-Aspitia, Alvaro, O’Shannessy, Daniel J., Maltzman, Julia D., McCullough, Ann E., Pockaj, Barbara A., Cunliffe, Heather E., Ballman, Karla V., Thompson, E. Aubrey, Perez, Edith A.
Publicado no PLoS One (2015)